SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wolfe F. Fibromyalgia, the clinical syndrome. Rheum Dis Clin NA. 1989;15:1 17.
  • 2
    Goldenberg DL. Fibromyalgia syndrome a decade later: what have we learned?. Arch Intern Med. 1999;159:777 85.
  • 3
    Hudson JL, Goldenberg DL, Pope Hg Jr, Keck Pe Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992;92:363 7.
  • 4
    Triadafilopoulos G, Simms RW, Goldenberg DL. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci. 1991;36:59 64.
  • 5
    Ahles TA, Khan SA, Yunus MB, Spiegell DA, Masi AT. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry. 1991;148:1721 6.
  • 6
    Yunus MB, Ahles TA, Aldag JA, Masi AT. Relationships of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum. 1991;34:15 21.
  • 7
    Onghena P & Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain. 1992;49:205 19.
  • 8
    McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996;68:217 27.DOI: 10.1016/s0304-3959(96)03140-5
  • 9
    Jung AC, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med. 1997;12:384 9.
  • 10
    The Cochrane Collaboration. The Cochrane Library. Oxford, United Kingdom: Update Software; 1999 (updates quarterly).
  • 11
    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1 12.DOI: 10.1016/0197-2456(95)00134-4
  • 12
    Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629 34.
  • 13
    DerSimonian R & Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177 88.
  • 14
    Carrette S, McCain GA, Bell DA, Fam AG. Evaluation of amitriptyline in primary fibrositis. A double-blind placebo-controlled study. Arthritis Rheum. 1986;29:655 9.
  • 15
    Carrette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placbo in the treatment of fibromyalgia. A randomized double blind clinical trial. Arthritis Rheum. 1994;1:32 40.
  • 16
    Carrette S, Oakson G, Guimont C, Steriade M. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum. 1995;38:1211 7.
  • 17
    Ginsberg F, Mancaux A, Joos E, Vanhove P, Famaey JP. A randomized placebo-controlled trial of sustained-release amitriptyline in primary fibromyalgia. J Musculoskeletal Pain. 1996;4:37 47.
  • 18
    Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum. 1986;29:1371 7.
  • 19
    Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol. 1991;18:447 51.
  • 20
    Scudds RA, McCain GA, Rollman GB, Harth M. Improvements in pain responsiveness in patients with fibrosists after successful treatment with amitriptyline. J Rheumatol. 1989;16:98 103.
  • 21
    Bibolotti E, Borghi C, Pasculli E, et al. A double-blind comparison of maprotiline and placebo. Clin Trials J. 1986;23:269 80.
  • 22
    Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol. 1998;37:1279 86.
  • 23
    Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind, crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthitis Rheum. 1996; 39:1852 9.
  • 24
    Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994; 23:255 9.
  • 25
    Norregaard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain. 1995;61:445 9.DOI: 10.1016/0304-3959(94)00218-4
  • 26
    Jacobsen S, Danneskiold-Samsoe B, Bach Andersen R. Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation. Scand J Rheumatol. 1991;20:294 302.
  • 27
    Tavoni A, Vitali C, Bombardieri S, Pasero G. Evaluation of s-adenosylmethionine in primary fibromyalgia: a double-blind crossover study. Am J Med. 1987;83(suppl 5A):107 10.
  • 28
    Olin R, Klein R, Berg PA. A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides, and phospholipids. Clin Rheumatol. 1998;17:89 94.
  • 29
    Kempenears CH, Simenon G, Vander Elst M, Fransolet L, Mingard P, De Maertelaer V. Effect of an antidiencephalon immune serum on pain and sleep in primary fibromyalgia. Neuropsychobiology. 1994; 30:66 72.
  • 30
    Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160 72.
  • 31
    Cohen J. Statistical power analysis for the behavioral sciences. New York, NY: Academic Press; 1969.
  • 32
    Yunus MD, Kalayan-Raman UP, Masi AT, Aldag AT. Electromicroscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol. 1989; 16:97 101.
  • 33
    Simms RW, Roy SH, Hrovat M, et al. Lack of association between fibromyalgia syndrome and abnormalities and muscle energy metabolism. Arthritis Rheum. 1994;37:794 800.
  • 34
    Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum. 1997;40:1928 39.
  • 35
    Arroyo JF & Cohen ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol. 1993;20:1925 31.
  • 36
    Kosek E, Ekholm J, Hansson P. Increased pressure pain sensibility in fibromyalgia patients is located deep in the skin but not restricted to muscle tissue. Pain. 1995;63:335 9.DOI: 10.1016/0304-3959(95)00061-5
  • 37
    Kosek E, Ekholm J, Hansson P. Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain. 1996;64:415 23.DOI: 10.1016/0304-3959(95)00112-3
  • 38
    Drewes AM, Gade J, Nielsen KD, Bjerregard K, Taaghholt SJ, Svendsen L. Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome. Arthritis Rheum. 1992;335:1151 6.
  • 39
    May KP, West SG, Baker MR, Everett DW. Sleep apnea in male patients with the fibromyalgia syndrome. Am J Med. 1993;94:505 8.
  • 40
    Yunus MB & Aldag JC. Restless leg syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ. 1996;312:1339.
  • 41
    MacFarlane JG, Shahal B, Mously C, Moldofsky H. Periodic K-alpha sleep EEG activity and periodic limb movements during sleep: comparisons of clinical features and sleep parameters. Sleep. 1996;19:200 4.
  • 42
    Tomkins GE, Jackson JL, O'Malley PG, Kroenke K, Balden E, Santoro JA. Treatment of chronic headache with anti-depressants: a meta-analysis. J Gen Intern Med. 1999;14(suppl 2):75.
  • 43
    Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis. Psychosom Med. 1998;60:503 9.
  • 44
    O'Malley PG, Jackson JL, Tomkins GE, Santoro JA, Balden E, Kroenke K. Efficacy of antidepressants for physical symptoms: a critical review. J Fam Pract. 1999;48:980 90.
  • 45
    Katon W, Kleinman A, Rosen G. Depression and somatization: a review. Am J Med. 1982;72:127 5, 241–7.
  • 46
    Kroenke K, Spitzer RL, Williams JBW, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774 9.
  • 47
    Smith GR. The epidemiology and treatment of depression when it coexists with somatoform disorders, somatization, or pain. Gen Hosp Psychiatry. 1992;14:265 72.
  • 48
    Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 1994;35(suppl):S50 3.
  • 49
    Chalmers TC. Effects of ascorbic acid on the common cold. Am J Med. 1973;58:532 6.